Teyi Pharmaceutical Group Co Ltd
Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of Chinese patented medicines, pharmaceutical preparations, raw materials, and products in the People's Republic of China. The company provides cough and phlegm, kidney, anti-infection, cardiovascular and cerebrovascular, and digestive system drugs, as well as pediatrics, dermatology, tuberculosis, res… Read more
Teyi Pharmaceutical Group Co Ltd (002728) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.025x
Based on the latest financial reports, Teyi Pharmaceutical Group Co Ltd (002728) has a cash flow conversion efficiency ratio of 0.025x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥45.44 Million) by net assets (CN¥1.80 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Teyi Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how Teyi Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Teyi Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Teyi Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Investis Holding SA
SW:IREN
|
0.016x |
|
DOM DEVELOPMENT SE.A.ZY 1
F:6WV
|
N/A |
|
Tinexta S.p.A.
LSE:0RIW
|
0.076x |
|
Procter & Gamble Health Limited
NSE:PGHL
|
0.278x |
|
SIPEF SA (POST SPLIT)
F:BZ3
|
N/A |
|
Luyan Pharma Co Ltd
SHE:002788
|
0.036x |
|
Chongqing Shunbo Aluminum Co Ltd
SHE:002996
|
-0.026x |
|
The Hongkong and Shanghai Hotels Limited
F:HSG
|
0.005x |
Annual Cash Flow Conversion Efficiency for Teyi Pharmaceutical Group Co Ltd (2009–2024)
The table below shows the annual cash flow conversion efficiency of Teyi Pharmaceutical Group Co Ltd from 2009 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.76 Billion | CN¥-22.55 Million | -0.013x | -112.94% |
| 2023-12-31 | CN¥2.01 Billion | CN¥198.56 Million | 0.099x | -62.72% |
| 2022-12-31 | CN¥1.40 Billion | CN¥371.66 Million | 0.265x | +30.13% |
| 2021-12-31 | CN¥1.26 Billion | CN¥256.81 Million | 0.204x | +30.14% |
| 2020-12-31 | CN¥1.08 Billion | CN¥168.99 Million | 0.156x | -18.63% |
| 2019-12-31 | CN¥1.15 Billion | CN¥221.64 Million | 0.192x | +13.64% |
| 2018-12-31 | CN¥1.11 Billion | CN¥187.97 Million | 0.169x | +71.34% |
| 2017-12-31 | CN¥1.04 Billion | CN¥102.96 Million | 0.099x | -13.59% |
| 2016-12-31 | CN¥886.57 Million | CN¥101.30 Million | 0.114x | +33.44% |
| 2015-12-31 | CN¥804.30 Million | CN¥68.87 Million | 0.086x | +9.84% |
| 2014-12-31 | CN¥735.64 Million | CN¥57.35 Million | 0.078x | -63.23% |
| 2013-12-31 | CN¥350.14 Million | CN¥74.23 Million | 0.212x | -42.12% |
| 2012-12-31 | CN¥285.34 Million | CN¥104.50 Million | 0.366x | +18.31% |
| 2011-12-31 | CN¥225.51 Million | CN¥69.81 Million | 0.310x | +12.70% |
| 2010-12-31 | CN¥170.81 Million | CN¥46.92 Million | 0.275x | +26.99% |
| 2009-12-31 | CN¥103.18 Million | CN¥22.32 Million | 0.216x | -- |